MarketBeat Instant News Alerts 2 hours agoVir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 48MarketBeatVir Biotechnology (NASDAQ:VIR) said its combination treatment for chronic hepatitis delta met the primary and key secondary endpoints in the pivotal Phase III ECLIPSE 1 trial, with 79% of treated patients achieving undetectable virus at 48 weeks. The company also presented longer-term Phase II dataNASDAQ:VIRRead Vir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 482 hours agoDouglas Elliman Q3 Earnings Call HighlightsMarketBeatDouglas Elliman (NYSE:DOUG) reported a third-quarter profit as a prior-year charge tied to convertible debt fell away, but its adjusted loss widened and revenue declined from a year earlier. The luxury residential brokerage posted net income of $7.4 million, or $0.08 per diluted share, for the quarNYSE:DOUGRead Douglas Elliman Q3 Earnings Call Highlights2 hours agoGroupon Q3 Earnings Call HighlightsMarketBeatGroupon (NASDAQ:GRPN) reported third-quarter billings growth near the top of its guidance range, but revenue and adjusted EBITDA fell short as customer refunds and marketing spending weighed on results. Billings rose 6% year over year to $439 million, while revenue increased 2% to $125 million and NASDAQ:GRPNRead Groupon Q3 Earnings Call Highlights2 hours agoNational Health Investors (NYSE:NHI) Issues FY 2026 Earnings GuidanceMarketBeatNational Health Investors (NYSE:NHI) updated its FY 2026 earnings guidance. The company provided EPS guidance of 4.680-4.700 for the period, compared to the consensus estimate of 4.760. NYSE:NHIRead National Health Investors (NYSE:NHI) Issues FY 2026 Earnings Guidance2 hours agoLantronix (NASDAQ:LTRX) Issues Q2 2027 Earnings GuidanceMarketBeatLantronix (NASDAQ:LTRX) updated its second quarter 2027 earnings guidance. The company provided EPS guidance of 0.040-0.060 for the period, compared to the consensus estimate of 0.040. The company also issued revenue guidance of $32.5 million-$34.5 million, compared to the consensus estimate of $33.5 million. NASDAQ:LTRXRead Lantronix (NASDAQ:LTRX) Issues Q2 2027 Earnings Guidance2 hours agoQualys (NASDAQ:QLYS) Issues Q4 2026 Earnings GuidanceMarketBeatQualys (NASDAQ:QLYS) updated its fourth quarter 2026 earnings guidance. The company provided EPS guidance of 2.050-2.120 for the period, compared to the consensus estimate of 1.860. The company also issued revenue guidance of $191.0 million-$193.0 million, compared to the consensus estimate of $190.9 million. NASDAQ:QLYSRead Qualys (NASDAQ:QLYS) Issues Q4 2026 Earnings Guidance Trending News1Trisura Group (TSE:TSU) Hits New 52-Week Low - Here's Why2What IonQ (IONQ) Said on Its Q3 Earnings Call3BlackBerry (NYSE:BB) Director David Chaikof Acquires 5,000 Shares of Company Stock4Life360 (NASDAQ:LIF) Stock Falls 5.2% - Here's Why5What IREN (IREN) Said on Its Q1 Earnings Call6What Applied Optoelectronics (AAOI) Said on Its Q3 Earnings Call7Floor & Decor Holdings, Inc. $FND Holdings Cut by VIRGINIA RETIREMENT SYSTEMS ET Al8Trump Media & Technology Group (NASDAQ:DJT) Stock Sees Heavy Put Option Buying All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoQualys (NASDAQ:QLYS) Announces FY 2026 Earnings GuidanceMarketBeatNASDAQ:QLYSRead Qualys (NASDAQ:QLYS) Announces FY 2026 Earnings Guidance2 hours agoAmeresco (NYSE:AMRC) Announces FY 2026 Earnings GuidanceMarketBeatNYSE:AMRCRead Ameresco (NYSE:AMRC) Announces FY 2026 Earnings Guidance2 hours agoTronox (NYSE:TROX) Director Peter Johnston Purchases 20,000 Shares of StockMarketBeatNYSE:TROXRead Tronox (NYSE:TROX) Director Peter Johnston Purchases 20,000 Shares of Stock2 hours agoInsider Selling: AGCO (NYSE:AGCO) SVP Sells $1,363,230.00 in StockMarketBeatNYSE:AGCORead Insider Selling: AGCO (NYSE:AGCO) SVP Sells $1,363,230.00 in Stock2 hours agoAGCO (NYSE:AGCO) SVP Torsten Rudolf Willi Dehner Sells 15,000 Shares of StockMarketBeatNYSE:AGCORead AGCO (NYSE:AGCO) SVP Torsten Rudolf Willi Dehner Sells 15,000 Shares of Stock2 hours agoUnited Parks & Resorts (NYSE:PRKS) Given New $56.00 Price Target at GuggenheimMarketBeatNYSE:PRKSRead United Parks & Resorts (NYSE:PRKS) Given New $56.00 Price Target at Guggenheim2 hours agoRoyal Bank Of Canada Reaffirms "Sector Perform" Rating for Plug Power (NASDAQ:PLUG)MarketBeatNASDAQ:PLUGRead Royal Bank Of Canada Reaffirms "Sector Perform" Rating for Plug Power (NASDAQ:PLUG)2 hours agoONEOK (NYSE:OKE) Stock Rated Equal Weight in New Coverage at BarclaysMarketBeatNYSE:OKERead ONEOK (NYSE:OKE) Stock Rated Equal Weight in New Coverage at Barclays2 hours agoKKR & Co. Inc. (NYSE:KKR) Given "Outperform" Rating at Royal Bank Of CanadaMarketBeatNYSE:KKRRead KKR & Co. Inc. (NYSE:KKR) Given "Outperform" Rating at Royal Bank Of Canada2 hours agoTrade Desk (NASDAQ:TTD) Price Target Raised to $18.00MarketBeatNASDAQ:TTDRead Trade Desk (NASDAQ:TTD) Price Target Raised to $18.002 hours agoZeta Global (NYSE:ZETA) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysMarketBeatNYSE:ZETARead Zeta Global (NYSE:ZETA) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says2 hours agoGuggenheim Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) StockMarketBeatNASDAQ:ADPTRead Guggenheim Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock2 hours agoTrade Desk (NASDAQ:TTD) Stock Gets Price Target Increase from GuggenheimMarketBeatNASDAQ:TTDRead Trade Desk (NASDAQ:TTD) Stock Gets Price Target Increase from Guggenheim2 hours agoGuggenheim Forecasts Strong Price Appreciation for Arhaus (NASDAQ:ARHS) StockMarketBeatNASDAQ:ARHSRead Guggenheim Forecasts Strong Price Appreciation for Arhaus (NASDAQ:ARHS) Stock2 hours agoReddit (NYSE:RDDT) Stock Gets Price Target Reduction from GuggenheimMarketBeatNYSE:RDDTRead Reddit (NYSE:RDDT) Stock Gets Price Target Reduction from Guggenheim2 hours agoVia Transportation (NYSE:VIA) Stock Gets Price Target Bump from GuggenheimMarketBeatNYSE:VIARead Via Transportation (NYSE:VIA) Stock Gets Price Target Bump from Guggenheim2 hours agoAmeresco (NYSE:AMRC) Releases Q4 2026 Earnings GuidanceMarketBeatNYSE:AMRCRead Ameresco (NYSE:AMRC) Releases Q4 2026 Earnings Guidance2 hours agoAmerican Public Education (NASDAQ:APEI) Releases Q4 2026 Earnings GuidanceMarketBeatNASDAQ:APEIRead American Public Education (NASDAQ:APEI) Releases Q4 2026 Earnings Guidance2 hours agoAmerican Public Education (NASDAQ:APEI) Issues FY 2026 Earnings GuidanceMarketBeatNASDAQ:APEIRead American Public Education (NASDAQ:APEI) Issues FY 2026 Earnings Guidance2 hours agoRackspace Technology (NASDAQ:RXT) Announces FY 2026 Earnings GuidanceMarketBeatNASDAQ:RXTRead Rackspace Technology (NASDAQ:RXT) Announces FY 2026 Earnings Guidance2 hours agoH&R Block (NYSE:HRB) Announces FY 2027 Earnings GuidanceMarketBeatNYSE:HRBRead H&R Block (NYSE:HRB) Announces FY 2027 Earnings Guidance2 hours agoPaysign (NASDAQ:PAYS) Releases FY 2026 Earnings GuidanceMarketBeatNASDAQ:PAYSRead Paysign (NASDAQ:PAYS) Releases FY 2026 Earnings Guidance2 hours agoOnto Innovation (NYSE:ONTO) Announces Q4 2026 Earnings GuidanceMarketBeatNYSE:ONTORead Onto Innovation (NYSE:ONTO) Announces Q4 2026 Earnings Guidance2 hours agoMARA (NASDAQ:MARA) Given Neutral Rating at GuggenheimMarketBeatNASDAQ:MARARead MARA (NASDAQ:MARA) Given Neutral Rating at Guggenheim Featured Articles and OffersLemonade's Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?By Thomas Hughes | November 8, 2026Every Starlink dish pays this stockFrom Behind the Markets (Ad)Marriott's Earnings Beat Shows Why It's More Than a Bet on Travel DemandBy Chris Markoch | November 3, 2026Wall Street May Be Making a Big Mistake With monday.com StockBy Thomas Hughes | November 9, 2026Uber's Profit Drop: A Speed Bump or Structural Shift?By Jeffrey Neal Johnson | November 5, 2026Your free book is about to disappearFrom Profits Run (Ad)Why ExxonMobil and Chevron Reminded Investors to Keep it SimpleBy Chris Markoch | November 4, 2026CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?By Dan Schmidt | November 6, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 426 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
